Avanir Pharmaceuticals and its subsidiaries acquire, develop, and commercialize novel therapeutic products for the treatment of central nervous system disorders. Avanir’s primary product is NUEDEXTA for the treatment of pseudobulbar affect. Avanir’s product line also comprises AVP-923 for the treatment of central neuropathic pain in patients with multiple sclerosis and for the treatment of patients with diabetic peripheral neuropathic pain, as well as treatment for cold sores. For more information visit the company’s Web site at www.avanir.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: